Guggenheim Maintains Buy on Twist Bioscience, Raises Price Target to $212

Benzinga · 1d ago
Guggenheim analyst Subbu Nambi maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $107 to $212.